Skip to main content

Home/ Groups/ Harwood Nuclear Chem
wizardbrown

Nuclear reactor - Wikipedia, the free encyclopedia - 0 views

  • A nuclear reactor is a device to initiate and control a sustained nuclear chain reaction. Nuclear reactors are used at nuclear power plants for electricity generation and in propulsion of ships. Heat from nuclear fission is passed to a working fluid (water or gas), which runs through turbines. These either drive a ship's propellers or turn electrical generators.
  • When a large fissile atomic nucleus such as uranium-235 or plutonium-239 absorbs a neutron, it may undergo nuclear fission. The heavy nucleus splits into two or more lighter nuclei, (the fission products), releasing kinetic energy, gamma radiation, and free neutrons. A portion of these neutrons may later be absorbed by other fissile atoms and trigger further fission events, which release more neutrons, and so on. This is known as a nuclear chain reaction. To control such a nuclear chain reaction, neutron poisons and neutron moderators can change the portion of neutrons that will go on to cause more fission.[2] Nuclear reactors generally have automatic and manual systems to shut the fission reaction down if monitoring detects unsafe conditions.[3] Commonly-used moderators include regular (light) water (in 74.8% of the world's reactors), solid graphite (20% of reactors) and heavy water (5% of reactors). Some experimental types of reactor have used beryllium, and hydrocarbons have been suggested as another possibility.[2][not in citation given]
daym2015

Nuclear Reactors | Nuclear Power Plant | Nuclear Reactor Technology - 0 views

  • A nuclear reactor produces and controls the release of energy from splitting the atoms of certain elements. In a nuclear power reactor, the energy released is used as heat to make steam to generate electricity. (
  • nuclear reactor produces and controls the release of energy from splitting the atoms of certain elements. In a nuclear power reactor, the e
vikram1997

The Iran Case: Addressing Why Countries Want Nuclear Weapons | Arms Control Association - 0 views

  • Iran’s possible development of nuclear weapons has now come front and center in U.S. foreign policy, as well as in consideration overall of preventing the spread of weapons of mass destruction. It has assumed particular importance because of its potential to reshape the security and politics of an already turbulent and critical region. In the middle of the Middle East, such a capability would at the very least lead to a basic reassessment by countries near and far of a full range of security, political, and other issues. As the saga of a widely presumed but not admitted Iranian nuclear weapons program unfolds, with its on-again, off-again character, something else is happening: the need for a reassessment of nonproliferation—both how to prevent proliferation and what to do if prevention fails. There is dwindling confidence that a country bent on developing nuclear weapons can forever be prevented from doing so by the now-traditional technological safeguards. In particular, it appears less possible to block the indigenous development of either plutonium or highly enriched uranium, the essential materials for nuclear weapons. Talent and knowledge are not a constraint, and access to fissionable materials may be an ever decreasing one to a country’s nuclear ambitions.
  • Most importantly, we need to ask why Iran or any other country would want to acquire nuclear weapons in the first place. Then we must see whether and, within appropriate limits, how the country in question can be dissuaded from developing those weapons. The recent Iranian pause in its enrichment activities allows the West, particularly the United States, the opportunity to explore this possibility before either resorting to military force or merely fretting that Iran is on the path to the destabilizing development of nuclear weapons.
  • To be sure, the United States and its allies have reasons to be bothered about Iran’s behavior, such as its support for terrorist groups such as Hezbollah. But Iran also has reason to be concerned about its security. Its principal antagonist, the United States, for many years not only practiced its dual containment policy against Iran (and Iraq) but also supported expatriate groups bent on overthrowing the regime in Tehran, including through violent means. Regime change in Tehran has been a recurrent theme in U.S. policy as it has been consistently in the policy of Israel, which also strongly supported the U.S. invasion of Iraq. Iran was accorded a place in the U.S. “axis of evil” and is now even more vulnerable than only a few years ago to nearby U.S. military power. However legitimate these U.S. policies and actions may be, along with the animosity toward Iran of some key regional countries, they do provide an objective basis for Iranian security concerns.
  • ...6 more annotations...
  • One frequently expressed concern is that Iran would consider its nuclear weapons capability to be held in trust for the Islamic world or would give custody of a weapon to someone else, perhaps even a terrorist group. Such an outcome is theoretically possible, but not very probable. With one notable and quickly regretted exception—Soviet transfer of some U-235 to China in the 1950s—no country with bomb-making fissionable materials has knowingly transferred them to anyone else.
  • More useful to consider is the role that nuclear weapons would play in shaping post-nuclear Iran’s relationships with its neighbors—friends and foes. When all is said and done, such weapons would have little military utility except for deterrence. This would operate at four levels: to deter a conventional attack from a non-nuclear regional power; to deter an openly nuclear regional state—today only including Pakistan and India; to deter Israel; or to deter a major external power, notably the United States but, in theory at least, also including Russia.
  • The first case is obvious: no country with just conventional arms is likely to try the patience of a nuclear power. But in the other three cases, “proportional deterrence” would come into play. Originally developed by France, this doctrine holds that a relatively less-capable nuclear power such as Iran can deter a much stronger nuclear power (the United States, Russia, Pakistan, India, Israel) if it is viewed as able and willing to destroy “value targets” in the attacking nation even while it is being obliterated. This complex doctrine can be summarized as the “death throes” of a country under nuclear or even extreme conventional attack
  • Such a doctrine depends on the potential attacker such as the United States or Israel calculating that the targets in its own country that would be destroyed in retaliation would be more “valuable” to it than the benefit (military or political) of annihilating Iran. Of course, proportional deterrence can only succeed if the potential retaliation is credible, hence the need for a survivable second-strike capability. The threat of retaliation must not be so precise that the original attacking nation can calculate with precision whether the game is worth the candle (uncertainty principle). There should also be a margin for the leadership of the attacked nation to over-respond (irrationality principle). All these ideas were worked out in detail during the Cold War.
  • Nevertheless, as with all issues involving nuclear weapons, psychology and politics are critical elements. Indeed, if they were not—if the world had not witnessed Hiroshima and Nagasaki—we would likely have seen much more proliferation over the past 60 years, as many analysts long predicted, or even the further use of nuclear weapons in war.
  • As things now stand in the Middle East and are likely to stand for the foreseeable future, a nuclear-armed Iran would change the politics and the security of the region dramatically in terms of perceptions. The point need hardly be spelled out. Further, even if regional and outside countries could in time adjust to a nuclear-armed Iran, judged from today, it is highly unlikely that Iran would be permitted to gain such a capability. The United States, Israel, or perhaps some third-party would likely use whatever means necessary to prevent Iran from ever getting into that position.
  •  
    What happens if Iran gets bomb?
gabb_03

What are transfusions? - 0 views

  • What are transfusions?
  • A transfusion (trans-few-zhun) is putting blood or some part of it in a vein through an intravenous (IV) line. Transfusions of blood and blood products temporarily replace parts of the blood when a person has been bleeding, or when their body can’t make enough blood. The blood usually comes from another person, called a donor. Blood transfusions save millions of lives in the United States every year. People usually donate whole blood – blood taken right out of a vein through a needle. This whole blood may be called a unit or pint of blood, and equals about 450 milliliters or 16.7 ounces. But whole blood is rarely given as a transfusion. Blood has many parts (components), such as red blood cells, white blood cells, platelets (plate-lets), plasma, clotting factors, and small proteins. Each component does a different job. After it’s donated, whole blood is usually separated into components. This lets doctors give patients only the part they need. It also helps to get the most out of the donated blood.
  •  
    transfussion treatment
gabb_03

Lasers in Cancer Treatment - 0 views

  • Lasers in Cancer Treatment
  •  
    laser treatment
gabb_03

Photodynamic Therapy - 0 views

  • What is photodynamic therapy?
  • Photodynamic therapy or PDT is a treatment that uses special drugs, called photosensitizing agents, along with light to kill cancer cells. The drugs only work after they have been activated or “turned on” by certain kinds of light. PDT may also be called photoradiation therapy, phototherapy, or photochemotherapy. Depending on the part of the body being treated, the photosensitizing agent is either put into the bloodstream through a vein or put on the skin. Over a certain amount of time the drug is absorbed by the cancer cells. Then light is applied to the area to be treated. The light causes the drug to react with oxygen, which forms a chemical that kills the cells. PDT might also help by destroying the blood vessels that feed the cancer cells and by alerting the immune system to attack the cancer. The period of time between when the drug is given and when the light is applied is called the drug-to-light interval. It can be anywhere from a couple of hours to a couple of days, depending on the drug used
  •  
    photodynamic therapy
gabb_03

Types of stem cell transplants for treating cancer - 0 views

  • Types of stem cell transplants for treating cancer
  • In a typical stem cell transplant for cancer very high doses of chemo are used, often along with radiation therapy, to try to destroy all the cancer cells. This treatment also kills the stem cells in the bone marrow. Soon after treatment, stem cells are given to replace those that were destroyed. These stem cells are given into a vein, much like a blood transfusion. Over time they settle in the bone marrow and begin to grow and make healthy blood cells. This process is called engraftment
  •  
    stem cell transplant
gabb_03

What is cancer immunotherapy? - 0 views

  • What is cancer immunotherapy?
  •  
    what is immunotherapy
gabb_03

How does targeted therapy work? | The American Cancer Society - 0 views

  • How does targeted therapy work?
  • Targeted therapy is used to keep cancer from growing and spreading. To become cancer cells, normal cells go through a process called carcinogenesis (car-sin-oh-JEN-eh-sis). Cancer cells may then grow into tumors or reproduce throughout a body system, like blood cancers do. Scientists have learned a lot about the molecules that are part of this process and the signals a cell gets to keep this process going. Targeted therapy disrupts this process. The drugs target certain parts of the cell and the signals that are needed for a cancer to develop and keep growing. These drugs are often grouped by how they work or what part of the cell they target.
  •  
    how targeted therapy works
gabb_03

What is targeted therapy? | American Cancer Society - 0 views

  • What is targeted therapy?
  • As researchers have learned more about the gene changes in cells that cause cancer, they have been able to develop drugs that target these changes. Treatment with these drugs is often called targeted therapy. Targeted therapy drugs, like any drug used to treat cancer, are technically considered “chemotherapy.” But targeted therapy drugs do not work in the same ways as standard chemotherapy drugs. They are often able to attack cancer cells while doing less damage to normal cells by going after the cancer cells’ inner workings—the programming that sets them apart from normal, healthy cells. These drugs tend to have different (and often less severe) side effects than standard chemotherapy drugs. Targeted therapies are used to treat many kinds of diseases. Here we will focus on their use to treat cancer. In the past, only a few cancers could be treated with targeted therapy, but now these drugs are used to treat many different types of cancer. Targeted therapies are a major focus of cancer research today. Many future advances in cancer treatment will probably come from this field.
  •  
    what is targeted therapy
gabb_03

Questions about chemotherapy - 0 views

  • What is chemotherapy?
  • Chemotherapy is the use of strong drugs to treat cancer. You will often hear chemotherapy called “chemo,” (key-mo) but it’s the same treatment. Chemo was first used to treat cancer in the 1950s. It has helped many people live full lives. The chemo drugs your doctor or nurse gives you have been tested many times. Research shows they work to help kill cancer cells.
  •  
    what is chemotherapy
gabb_03

How is surgery used for cancer? - 0 views

  • How is surgery used for cancer?
  • Surgery can be done for many reasons. Some types of surgery are minor and may be called procedures, while others are much bigger operations. The more common types of cancer surgeries are reviewed here.
  •  
    surgery to cure cancer
ferriska2015

Radionuclide Ventriculography or Radionuclide Angiography (MUGA Scan) - 1 views

  • For example, an ejection fraction of 60 percent means that 60 percent of the total amount of blood in the left ventricle when it is full is pumped out with each heartbeat. A normal ejection fraction is between 50 and 75 percent.
  • Chest pain (angina)Trouble breathingDizzinessTiredness
  • Your heart may not be pumping enough blood to meet your body’s needs. This is called heart failure.
  • ...4 more annotations...
  • Your body will get rid of it through your kidneys within about 24 hours.
  • The disks have wires that hook to an electrocardiograph machine to record your ECG. The ECG tracks your heartbeat during the test. 
  • For an “exercise” scan, will generally walk on a treadmill or ride a stationary bicycle until you reach your peak activity level.
  • In some labs you may lie on a table and pedal a specially mounted bicycle
ferriska2015

MUGA Scan | Cancer.Net - 1 views

  • cardiac blood pooling imaging, nuclear heart scan, nuclear ventriculography, and radionuclide ventriculography.
  • Some people with cancer who receive chemotherapy or other drugs may need this test before cancer treatment to identify preexisting heart conditions or during or after cancer treatment to identify chemotherapy-related heart damage.
  • side effects that occur more than five years after treatment
  • ...18 more annotations...
  • chemotherapy, such as anthracyclines, may damage the heart during cancer treatment.
  • heart damage from these drugs can cause congestive heart failure (CHF; a condition in which the heart does not pump enough blood to the rest of the body)
  • arrhythmia (an irregular heartbeat)
  • heart damage is mild and is only detected on MUGA scans
  • performed by a nuclear medicine technologist who has been specially trained and certified to conduct the test
  • The technologist is supervised by a radiologist (a medical doctor who specializes in using imaging tests to diagnose disease) or a nuclear medicine physician. The scan results are interpreted by a radiologist.
  • place stickers called electrodes on your chest to monitor your heart’s electrical activity during the test and inject a small amount of a radioactive material, called a tracer, into a vein in your arm. Sometimes the test is done by withdrawing a small amount of blood from your arm, mixing it with the tracer, and then putting that mixture back into your body through an IV (a tiny plastic tube inserted directly into a vein).
  • The radioactive material is like a dye, and it binds to your red blood cells (cells that carry oxygen throughout your body), making it easier to see how blood moves through your heart.
  • special camera—which is about three feet wide and uses gamma rays to track the tracer—above your chest.
  • nitroglycerin (multiple brand names; a drug that opens your blood vessels) during the test to see how your heart responds to the medication.
  • two to three hours to complete
  • ejection fraction (the amount of blood pumped out of the ventricles).
  • A result of 50% or higher is considered normal, meaning that your heart is efficiently pumping blood throughout your body
  • an abnormal result may mean you have a blockage in an artery, poor pumping function, heart valve disease, or other disorder.
  • switch treatments or give you a different type of chemotherapy.
  • What are the risks and benefits of having a MUGA scan?
  • What will happen if I don’t have this procedure?
  • What will happen during the procedure?
« First ‹ Previous 41 - 60 of 81 Next › Last »
Showing 20 items per page